Lyell Immunopharma, Inc. (LYEL) SEC Filings — 2024
17 SEC filings for Lyell Immunopharma, Inc. (LYEL) in 2024.
Filings
- Lyell Immunopharma Files 8-K — 8-K · Dec 10, 2024
- Lyell Immunopharma Reports Board and Executive Changes — 8-K · Nov 26, 2024
- Lyell Immunopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Lyell Immunopharma Files Q3 2024 10-Q Report — 10-Q · Nov 7, 2024
- Lyell Immunopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Lyell Immunopharma Files 8-K on Agreements and Asset Changes — 8-K · Oct 31, 2024
- Lyell Immunopharma, Inc. SC 13G Filing — SC 13G · Oct 31, 2024
- Lyell Immunopharma Files 8-K with Key Agreements and Equity Sales — 8-K · Oct 24, 2024
- Lyell Immunopharma Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Lyell Immunopharma Files 8-K with Financials — 8-K · Jun 26, 2024
- Lyell Immunopharma Files 8-K on Shareholder Vote Matters — 8-K · Jun 14, 2024
- Lyell Immunopharma Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
- Lyell Immunopharma Announces 2024 Annual Meeting of Stockholders on June 14 — DEF 14A · Apr 22, 2024
- Lyell Immunopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Lyell Immunopharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Lyell Immunopharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Discloses Significant Passive Stake in Lyell Immunopharma — SC 13G · Jan 29, 2024